Wild Child sued over recalled sunscreen SPF claims


The sun doesn’t wait for lawsuits, and neither should your sunscreen. A major dispute is unfolding in the cosmetics industry, pitting a manufacturer against a major brand over serious allegations of misleading claims regarding sun protection. At the heart of the controversy is Wild Child Laboratories, an Australian manufacturer caught in a chain reaction that highlights the complex accountability of shared formulas and third-party testing.

The fallout began when Ultra Violette’s Lean Screen SPF50+ sunscreen was recalled. This action stemmed from testing conducted by the consumer group Choice, which reportedly revealed that the product’s actual SPF rating was only four, dramatically falling short of the advertised protection.

The ensuing investigation quickly pointed back to the foundation of the problem: the base formula. Wild Child Laboratories was responsible for manufacturing the core formula used in the recalled product, as well as nineteen other sunscreens that subsequently faced similar low SPF test results. This interconnected manufacturing process brought the issue directly to the forefront of a massive legal challenge.

Ultra Violette is now seeking millions of dollars in damages, arguing that the discrepancy in SPF claims caused significant commercial harm. This legal battle has exposed critical questions about manufacturer accountability, the rigor of SPF testing standards, and the commercial risks brands take when relying on shared formulations.

Facing the financial weight of the situation, Wild Child Laboratories entered voluntary liquidation in August. Creditors, including major sunscreen brands and the Australian Taxation Office, are collectively claiming debts amounting to approximately A$20 million. This process marked a significant shift in ownership, as the company’s assets were subsequently sold to Heliora, a new entity that shares the same leadership and continues the crucial work of sunscreen manufacturing.

Despite the sale, Heliora has firmly rejected any suggestions that the transition was designed merely to circumvent Wild Child’s liabilities. The dispute serves as a stark reminder that in the world of beauty products, the integrity of the ingredients and the honesty of the claims are paramount, ensuring that consumers are protected from misleading promises and that manufacturers bear the full weight of their responsibilities.

You may also like: